Among these 50 participants (clb+ and hosting >1 isolate), 38 were CRC patients and only 12 were controls, a 3.2:1 ratio, in contrast to a balanced 1:1 ratio in those participants who hosted just one isolate, making the difference highly significant (p = 0.016). Here, CLYBL is linked to colorectal carcinoma.